This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Marie-Anne Rey Cuille: Innovator in Immunogenic Compositions
Introduction
Marie-Anne Rey Cuille, a distinguished inventor based in Paris, France, has made significant contributions to the field of immunology. Her innovative work in developing immunogenic compositions is aimed at combating human immunodeficiency virus type 2 (HIV-2), highlighting her commitment to advancing healthcare through scientific research.
Latest Patents
Marie-Anne Rey Cuille holds a noteworthy patent entitled "Immunogenic compositions comprising glycosylated and deglycosylated." This invention focuses on a composition that includes one or more envelope proteins derived from HIV-2, specifically gp300, p200, and p90/80, combined with a pharmaceutically acceptable carrier. These compositions are not only critical for diagnostic assays of HIV-2 but also serve as antigens for the production of antibodies, demonstrating their potential in biomedical applications.
Career Highlights
Marie-Anne has built her career at two prestigious institutions: Institut Pasteur and the Centre Nationale de La Recherche Scientifique. Her work has established her as a pivotal figure in the research community, contributing to a greater understanding of viral immunology and the development of therapeutic strategies against HIV-2.
Collaborations
Throughout her career, Marie-Anne has collaborated with eminent scientists like Luc Montagnier and Anne G. Laurent-Crawford. These partnerships have enriched her research and have been instrumental in driving forward the collective goal of addressing the challenges posed by HIV.
Conclusion
Marie-Anne Rey Cuille exemplifies the spirit of innovation in science, particularly through her work on immunogenic compositions for HIV-2. Her dedication to research and collaboration has not only impacted the scientific community but also holds promise for improving health outcomes in the broader population.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
